Pere Barba
Barcelona, CT, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 168 publications
Timing of Allogeneic Hematopoietic Cell Transplantation After Inotuzumab Ozogamicin Influences Sinusoidal Obstruction Syndrome and Survival in Relapsed/Refractory B-ALL.
Journal: Transplantation and cellular therapy
Published: June 15, 2026
Real-world CAR-T practice patterns in patients with mantle cell lymphoma: an international survey on behalf of the EBMT lymphoma working party.
Journal: Bone marrow transplantation
Published: April 12, 2026
Correction: Pourroy et al. High-Dose Methotrexate at All Ages: Safety, Efficacy, and Outcomes from the HDMTX European Registry. Cancers 2026, 18, 124.
Journal: Cancers
Published: February 26, 2026
CAR T-cell Kinetics, Persistence, and Clinical Outcomes in Adult Patients with Relapsed/Refractory B-cell ALL Treated with Obecabtagene Autoleucel in the FELIX Study.
Journal: Cancer research communications
Published: December 17, 2025
Impact of fludarabine exposure on CAR T-cell outcomes in patients with large B-cell lymphoma.
Journal: Blood advances
Published: December 04, 2025
Impact of fludarabine exposure on CAR T-cell outcomes in patients with large B-cell lymphoma.
Journal: Blood advances
Published: December 04, 2025
Unveiling CMV Risk Signatures After Allogeneic Stem Cell Transplantation Through Machine Learning Approaches: A Multicenter Analysis From the GETH-TC.
Journal: Journal of medical virology
Published: November 06, 2025
Towards Personalized Lymphodepletion: A Population Pharmacokinetic Fludarabine Model in Patients Receiving CAR T-Cell Therapy.
Journal: Pharmaceutics
Published: October 27, 2025
Last Updated: 09/26/2026